Spinal Tech

In this time of different coatings, materials and manufacturing processes, what are the factors important to surgeons when choosing an interbody fusion device?

In the first quarter of 2018, Stryker saw growth in all aspects of its business. The company released its financial results to provide further detail.

Stryker reported a 9.2 percent increase in first quarter sales to $3.2 billion, with a 7.1 percent increase in orthopedic sales year-over-year.

Zimmer Biomet CEO Bryan Hanson has been on a mission to improve company culture since taking the reins last year, and continues to focus on the cultural integration of Zimmer and Biomet, which officially merged in 2015.

A Los Angeles County jury found William Dobkin, MD, of Newport Beach, Calif.-based Hoag Hospital, not negligent in a case involving the off-label use of Medtronic's Infuse, according to Courtroom View Network.

Zimmer Biomet released its first quarter of 2018 financial results. While the company experienced an increase in net sales, other areas saw dips.

CoreLink named David Castleman its inaugural vice president of research and development.

Implanet reported first quarter revenue dropped 9 percent over the same time last year.

Zimmer Biomet partnered with Warsaw (Ind.) Community Schools to continuing expanding STEM initiatives, according to the Times Union Online.

Here are eight notes on orthopedic and spine device companies from the past week.